Home › Neuroblastoma
Pag-aaral pangklinika para sa Neuroblastoma na nagre-recruit sa U.S.
50 pag-aaral para sa Neuroblastoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Boston, MA13 pag-aaral
- New York City, NY12 pag-aaral
- Washington, DC11 pag-aaral
- Dallas, TX10 pag-aaral
- Cincinnati, OH9 pag-aaral
- St. Louis, MO9 pag-aaral
- Memphis, TN9 pag-aaral
- Philadelphia, PA9 pag-aaral
- Aurora, CO9 pag-aaral
- Hartford, CT8 pag-aaral
- Birmingham, AL8 pag-aaral
- Harrisburg, PA8 pag-aaral
- Minneapolis, MN8 pag-aaral
- Gainesville, FL7 pag-aaral
- Orlando, FL7 pag-aaral
- Miami, FL7 pag-aaral
- Los Angeles, CA7 pag-aaral
- Atlanta, GA7 pag-aaral
- San Francisco, CA7 pag-aaral
- Chicago, IL7 pag-aaral
- Durham, NC6 pag-aaral
- Oakland, CA6 pag-aaral
- Honolulu, HI6 pag-aaral
- Salt Lake City, UT6 pag-aaral
- Seattle, WA6 pag-aaral
- Greenburgh, NY6 pag-aaral
- Little Rock, AR6 pag-aaral
- Portland, OR6 pag-aaral
- Houston, TX6 pag-aaral
- Nashville, TN5 pag-aaral
- Charleston, SC5 pag-aaral
- San Diego, CA5 pag-aaral
- Columbus, OH5 pag-aaral
- Ann Arbor, MI5 pag-aaral
- Mountain View, CA5 pag-aaral
- Austin, TX5 pag-aaral
- Louisville, KY4 pag-aaral
- St. Petersburg, FL4 pag-aaral
- Kansas City, MO4 pag-aaral
- Milwaukee, WI4 pag-aaral
Ayos sa estado
- Alabama8 pag-aaral
- Arizona3 pag-aaral
- Arkansas6 pag-aaral
- California15 pag-aaral
- Colorado9 pag-aaral
- Connecticut9 pag-aaral
- District of Columbia6 pag-aaral
- Florida10 pag-aaral
- Georgia9 pag-aaral
- Hawaii6 pag-aaral
- Illinois7 pag-aaral
- Indiana3 pag-aaral
- Iowa3 pag-aaral
- Kentucky5 pag-aaral
- Maryland8 pag-aaral
- Massachusetts13 pag-aaral
- Michigan8 pag-aaral
- Minnesota9 pag-aaral
- Missouri10 pag-aaral
- New Jersey6 pag-aaral
- New York15 pag-aaral
- North Carolina7 pag-aaral
- North Dakota3 pag-aaral
- Ohio10 pag-aaral
- Oklahoma3 pag-aaral
- Oregon6 pag-aaral
- Pennsylvania16 pag-aaral
- Rhode Island3 pag-aaral
- South Carolina6 pag-aaral
- South Dakota3 pag-aaral
- Tennessee12 pag-aaral
- Texas15 pag-aaral
- Utah6 pag-aaral
- Virginia3 pag-aaral
- Washington6 pag-aaral
- Wisconsin6 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
Nagre-recruit
Hanggang edad 17 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06831552Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Nagre-recruitPhase 1/2
Hanggang edad 30 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06541262Naxitamab Enabled Transplant-Free Study in High-Risk Neuroblastoma
Nagre-recruitPhase 2
Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07932808A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Lahat ng edad · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT04936529A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
Nagre-recruitPhase 2
Lahat ng edad · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06057948A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06041516Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
Nagre-recruitPhase 1/2
Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07437963Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Nagre-recruitObservasyonal na pag-aaral
Edad 4 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT01005654PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy
Nagre-recruitPhase 1
Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT04837547Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Nagre-recruitPhase 3
Hanggang edad 30 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06172296Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Nagre-recruitPhase 1/2
6 Months – 25 Years · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06395103Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
Nagre-recruitPhase 2
Hanggang edad 30 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT02605421Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
Nagre-recruitPhase 1
7 Months – 21 Years · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT02508038International PPB/DICER1 Registry
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
0 Minutes – 100 Years · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT03382158Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma
Nagre-recruitPhase 1
Edad 3 hanggang 35 · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT06995872Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
4 Weeks · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT01109394Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
Nagre-recruitPhase 1
12 Months – 20 Years · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT02013336PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Nagre-recruitPhase 1/2
Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT06721689Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT00588068MCT for the Harvard/UCSF ROBIN Center
Nagre-recruit
Lahat ng edad · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06000787Biomarkers of Resiliency In Childhood Cancer Surgery
Nagre-recruitObservasyonal na pag-aaral
Edad 3 hanggang 25 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06674811Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Nagre-recruitPhase 2
Hanggang edad 22 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT02559778B7-H3.CD28Z.CART in Solid Tumors
Nagre-recruitPhase 1
9 Months – 30 Years · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07358260Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Nagre-recruitPhase 2
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06540963International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Set 3, 2026 · NCT03088020Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.